Curated News
By: NewsRamp Editorial Staff
June 18, 2026
MindBio's AI Voice Analysis Aims to Revolutionize Intoxication Detection
TLDR
- MindBio's AI voice analysis offers a non-invasive, rapid intoxication detection advantage for safety-sensitive industries.
- MindBio's AI models, trained on over 50 million data points, detect alcohol and drug intoxication via voice in under three seconds.
- MindBio's voice analysis technology can improve workplace safety by providing a non-invasive, scalable alternative to biological testing.
- MindBio's AI can detect intoxication from a person's voice, eliminating the need for blood or urine samples.
Impact - Why it Matters
This news matters because it introduces a transformative approach to workplace safety and public health. Traditional intoxication testing methods are invasive, time-consuming, and often require biological samples like blood or urine. MindBio's voice-based AI technology offers a non-invasive, rapid, and scalable alternative that could be deployed in high-risk industries such as mining, aviation, and construction, potentially reducing accidents and improving safety compliance. Moreover, the broader diagnostic potential for voice analytics could lead to earlier detection of neurological conditions, impacting healthcare delivery. For investors, this represents a novel application of AI in a large addressable market, with MindBio's extensive data set providing a competitive edge.
Summary
MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) is pioneering a non-invasive approach to detecting alcohol and drug intoxication through AI-powered voice analysis. CEO Justin Hanka recently discussed the company's plans on the TechMediaWire Podcast, revealing that MindBio has built prediction models using over 50 million data points from years of clinical research. These models can identify intoxication indicators from a person's voice, offering a scalable alternative to traditional biological sample testing. The company is developing enterprise deployment systems that combine proprietary software with Edge-AI kiosks capable of delivering assessments in under three seconds. MindBio expects to begin live workplace testing in the second quarter of 2026, targeting safety-sensitive industries such as mining, aviation, construction, and law enforcement.
The potential applications extend beyond workplace impairment detection. Management sees broader opportunities for AI-driven voice analytics as a diagnostic tool for identifying physiological and neurological conditions. This innovation could revolutionize how industries monitor safety, reducing reliance on invasive tests and enabling real-time, non-intrusive assessments. MindBio's technology is built on a robust foundation of clinical data, positioning it as a leader in the emerging field of voice-based biomarker analysis.
MindBio Therapeutics Corp., featured on BioMedWire, is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The company's AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy. For the latest updates, visit the company's newsroom at https://ibn.fm/MBQIF. BioMedWire is a specialized communications platform focusing on the latest developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, and is part of the Dynamic Brand Portfolio @ IBN.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, MindBio's AI Voice Analysis Aims to Revolutionize Intoxication Detection
